Leucine supplementation has been previously proposed as a therapeutic approach in other genetic disorders, including Roberts syndrome and Diamond-Blackfan anemia, that are also characterized by dysregulation of mTOR signaling, protein translation and autophagy [62–64]. This evidence concerns the gene MTOR and Roberts-SC phocomelia syndrome.